Surprisingly, a HEXB-focused reinterrogation of quantitative proteomics data of paired tissue samples from 96 CRC patients available from Clinical Proteomic Tumor Analysis Consortium (35) showed only mild (insignificant) increase of HEXB protein levels in TUM compared to NAT (Supplemental Fig. S4A). The gene discussed is BRD2; the disease is colorectal carcinoma.